Avery, R; Jiang, Z; Parida, A; Listernick, R; Liu, G; Ferner, R; Gutmann, D; de Blank, P; Lasky-Zeid, J; Ullrich, N; Reddy, A; Cutter, G; Linguraru, M; Fisher, M. NFS-24. TUMOR VOLUME IN NEWLY DIAGNOSED OPTIC PATHWAY GLIOMAS ASSOCIATED WITH NF1 (NF1-OPG): PRELIMINARY RESULTS FROM THE INTERNATIONAL MULTICENTER NF1-OPG NATURAL HISTORY STUDY. Neuro-Oncology. 2024; 26:0.

Bareja, R; Ismail, M; Martin, D; Nayate, A; Yadav, I; Labbad, M; Dullur, P; Garg, S; Tamrazi, B; Salloum, R; Margol, A; Judkins, A; Iyer, S; de Blank, P; Tiwari, P. nnU-Net-based Segmentation of Tumor Subcompartments in Pediatric Medulloblastoma Using Multiparametric MRI: A Multi-institutional Study. Radiology: Artificial Intelligence. 2024; 6:e230115.

Bartlett, AL; Wagner, JE; Jones, B; Wells, S; Sabulski, A; Fuller, C; Davies, SM. Fanconi anemia neuroinflammatory syndrome: brain lesions and neurologic injury in Fanconi anemia. Blood Advances. 2024; 8:3027-3037.

Bender, JD; Damodharan, S; Capitini, CM; Moskop, A; Toner, K; Vatsayan, A; Talano, JA; Baggott, C; Schiff, D; Katsanis, E; Modi, AJ; Quigg, TC; Raikar, SS; Schultz, LM; Pommert, L. Real-world use of tisagenlecleucel in children and young adults with relapsed or refractory B-cell lymphomas. Blood Advances. 2024; 8:4164-4168.

Bender, JD; Pillay-Smiley, N; Hill, GD; de Blank, P; Hummel, TR; Weiss, BD; Kumar, A; Zang, H; Ollberding, NJ; Ryan, TD. Cardiac Dysfunction in Children and Young Adults Treated With MEK Inhibitors: A Retrospective, Single-Center Study. JACC: CardioOncology. 2024; 6:794-796.

Blake, C; Widmeyer, K; DAquila, K; Mochizuki, A; Smolarek, TA; Pillay-Smiley, N; Kim, SY. 14q22.3 duplication including OTX2 in a girl with medulloblastoma: A case report with literature review. American Journal of Medical Genetics, Part A. 2024; 194:e63604.

Bouley, SJ; Grassetti, AV; Allaway, RJ; Wood, MD; Hou, HW; Burdon Dasbach, IR; Seibel, W; Wu, J; Gerber, SA; Dragnev, KH; Walker, JA; Sanchez, Y. Chemical genetic screens reveal defective lysosomal trafficking as synthetic lethal with NF1 loss. Journal of Cell Science. 2024; 137:jcs262343.

Cacciotti, C; Lenzen, A; Self, C; Pillay-Smiley, N. QOL-06. RECURRENCE PATTERNS AND SURVEILLANCE IMAGING IN PEDIATRIC BRAIN TUMOR SURVIVORS. Neuro-Oncology. 2024; 26:0.

Cacciotti, C; Lenzen, A; Self, C; Pillay-Smiley, N. Recurrence Patterns and Surveillance Imaging in Pediatric Brain Tumor Survivors. Journal of Pediatric Hematology/Oncology. 2024; 46:e227-e232.

Caisova, V; Rivero-Hinojosa, S; Tardito, S; Zhang, H; Lu, I; Chintala, N; Mochizuki, A; Pei, Y; Murad, N; Sneiderman, C; Kohanbash, G; Yang, J; Rood, B. MDB-45. THE PTBP2 SPLICING FACTOR IS ESSENTIAL IN GROUP 3/4 MEDULLOBLASTOMA. Neuro-Oncology. 2024; 26:0.

Campbell, P; Riazzi, A; Spitznagel, E; Schulte, M; Frias, O; Daugherty, M; Vanderbrink, B; DeFoor, W; Minevich, E; Reddy, P; Streich-Tilles, T; Burns, K; Strine, A. Time to therapy and safety of testicular tissue cryopreservation in children undergoing gonadotoxic treatment or hematopoietic stem cell transplant. Journal of Pediatric Urology. 2024; 20:747.e1-747.e7.

Cansanay, RD; Erker, C; Ratterman, E; Schlosser, MP; Ronsley, R; Cacciotti, C; Hukin, J; Cheng, S; Pillay-Smiley, N; Magimairajan, V; Rutkowski, S; Lassaletta, A; Bouffet, E; Lafay-Cousin, L. MDB-09. WNT AND GROUP 4 MEDULLOBLASTOMAS OF EARLY CHILDHOOD TREATED WITH HIGH DOSE CHEMOTHERAPY AND CRANIOSPINAL IRRADIATION SPARING APPROACH. Neuro-Oncology. 2024; 26:0.

Chang, YH; Yamamoto, K; Fujino, T; Wang, TW; Sugimoto, E; Zhang, W; Yabushita, T; Suzaki, K; Pietsch, EC; Weir, BA; Enomoto, Y; Imai, Y; Kitamura, T; Goyama, S. SETDB1 suppresses NK cell-mediated immunosurveillance in acute myeloid leukemia with granulo-monocytic differentiation. Cell Reports. 2024; 43:114536.

Chavana, AN; Taylor, ZL; DeGroote, N; Lindsay, HB; Sauer, HE; Mason, EJ; Schafer, ES; Miller, TP; Castellino, SM; Pommert, L; O'Brien, MM; Ramsey, LB; Bernhardt, MB; Brown, AL. Toxicity profile of high-dose methotrexate in young children with central nervous system tumors. Pediatric Blood and Cancer. 2024; 71:e31213.

Chi, SN; Lazow, M; Salloum, R; Lane, A; Hargrave, D; Witt, O; de Blank, P; Leary, SE S; Gorsi, H; Pierson, C; Yang, E; Mikael, L; Jones, DT W; Fouladi, M. TRLS-09. CONNECT1903: A PILOT AND SURGICAL STUDY OF LAROTRECTINIB FOR TREATMENT OF CHILDREN WITH NEWLY DIAGNOSED HGG WITH NTRK FUSION (NCT04655404). Neuro-Oncology. 2024; 26:0.

Cook, E; Dong, M; Chiang, SC C; Luedeke, D; Lake, KE; Hoerth, C; Deavy, M; Setchell, KD R; Zhao, J; Punt, N; Davies, SM; Marsh, RA; Mehta, P; Khandelwal, P. Ruxolitinib Pharmacokinetics and Pharmacodynamics in Children with Acute and Chronic Graft-versus-Host Disease. Transplantation and Cellular Therapy. 2024; 30:528.e1-528.e12.

Correia, D; Indelicato, DJ; Paulino, AC; Ermoian, R; Mihalcik, S; Perkins, SM; Hill-Kayser, C; Mangona, VS; Lee, J; Chang, JH C; Bajaj, BV M; Allison, KW; Perry, A; Yock, TI. Evolution of Proton Radiation Therapy Brainstem Constraints on the Pediatric Proton/Photon Consortium Registry. Practical Radiation Oncology. 2024; 14:e507-e514.

Culver-Cochran, AE; Hassan, A; Hueneman, K; Choi, K; Ma, A; VanCauwenbergh, B; O’Brien, E; Wunderlich, M; Perentesis, JP; Starczynowski, DT. Chemotherapy resistance in acute myeloid leukemia is mediated by A20 suppression of spontaneous necroptosis. Nature Communications. 2024; 15:9189.

D’Alessandro, PR; McGrady, ME; Nagata, JM; Norris, RE; Pressey, JG. Body Image Concerns in Adolescent and Young Adult Oncology Patients within Six Months of Upfront Diagnosis. Journal of Adolescent and Young Adult Oncology. 2024; 13:792-798.

Daugherty, EC; Zhang, Y; Xiao, Z; Mascia, AE; Sertorio, M; Woo, J; McCann, C; Russell, KJ; Sharma, RA; Khuntia, D; Bradley, JD; Simone, CB; Breneman, JC; Perentesis, JP. FLASH radiotherapy for the treatment of symptomatic bone metastases in the thorax (FAST-02): protocol for a prospective study of a novel radiotherapy approach. Radiation Oncology. 2024; 19:34.

de Blank, PM K; Lange, KR; Xing, M; Mirzaei Salehabadi, S; Srivastava, D; Brinkman, TM; Ness, KK; Oeffinger, KC; Neglia, J; Krull, KR; Leisenring, W; Armstrong, GT; Okcu, MF; Bowers, DC. Temporal changes in treatment and late mortality and morbidity in adult survivors of childhood glioma: a report from the Childhood Cancer Survivor Study. Nature Cancer. 2024; 5:590-600.

Desai, PB; Karve, AS; Zawit, M; Arora, P; Dave, N; Awosika, J; Li, N; Fuhrman, B; Medvedovic, M; Sallans, L; Zuccarello, M; Chaudhary, R; Sengupta, S; Wise-Draper, TM. A Phase 0/I Pharmacokinetic and Pharmacodynamics and Safety and Tolerability Study of Letrozole in Combination with Standard Therapy in Recurrent High-Grade Gliomas. Clinical Cancer Research. 2024; 30:2068-2077.

Doig, M; Kwok, Y; Lee, J; Macewan, I; Mangona, V; Laack, N; Wolden, S; Perentesis, J; Allison, K; Galloto, S; Gorayski, P; Le, H; Bezak, E; Yock, T. O114 / #164 DOSE TO ORGANS AT RISK IMPACTS HEALTH-RELATED QUALITY OF LIFE OUTCOMES FOR CHILDREN WITH BRAIN TUMORS. International Journal of Particle Therapy. 2024; 12:100227.

Duan, X; Evelyn, CR; Biesiada, J; Johnson, JF; Seibel, WL; Meller, J; Zheng, Y. Abstract 5912: Rational design of a small-molecule inhibitor targeting the allosteric site of sos1 in oncogenic k-ras pancreatic cancer. Cancer Research. 2024; 84:5912.

Fang, Z; Duan, C; Wang, S; Fu, L; Yang, P; Yu, T; Deel, MD; Lau, LM S; Ma, X; Ni, X; Su, Y. Pediatric spindle cell/sclerosing rhabdomyosarcoma with FUS-TFCP2 fusion: a case report and literature review. Translational Pediatrics. 2024; 13:178-191.

Fangusaro, J; Onar-Thomas, A; Poussaint, TY; Lensing, S; Ligon, AH; Lindeman, N; Banerjee, A; Kilburn, L; Lenzen, A; Pillay-Smiley, N; Jones, DT W; Stewart, CF; Fouladi, M; Dunkel, IJ. LGG-05. REPORT ON PEDIATRIC BRAIN TUMOR CONSORTIUM (PBTC)-029B, A PROSPECTIVE PHASE 2 CLINICAL TRIAL OF SELUMETINIB IN TREATING YOUNG PATIENTS WITH RECURRENT/PROGRESSIVE LOW-GRADE GLIOMA: NEW RESULTS ON STRATA 2, 5, AND 6 WITH UPDATED LONG-TERM SURVIVAL OUTCOMES ON STRATA 1, 3, AND 4. Neuro-Oncology. 2024; 26:0.

Farr, R; Bonn, J; Khorki, ME; Goldstein, S; Bondoc, A; Tiao, G; Somers, K; Geller, JI; Schuh, MP. Single-Center Case Series of Congenital Anomalies of the Kidney and Urinary Tract and Hepatoblastoma. Journal of the American Society of Nephrology : JASN. 2024; 35:10.1681/asn.20241j3dwf9j.

Fertitta, L; Bergqvist, C; Sarin, KY; Plotkin, SR; Moertel, C; Petersen, AK; Cannon, A; Berman, Y; Pichard, DC; Röhl, C; Jannic, A; Ezzedine, K; Wolkenstein, P; Response Evaluation in Neurofibromatosis and Schwa, . A core outcome domain set to assess cutaneous neurofibromas related to neurofibromatosis type 1 in clinical trials. British Journal of Dermatology. 2024; 190:216-225.

Fisher, MJ; de Blank, P; Listernick, R; Liu, G; Ferner, R; Gutmann, D; Lasky-Zeid, J; Ullrich, N; Heidary, G; Bornhorst, M; Esbenshade, A; Donahue, S; Cutter, G; Avery, R. NFS-21. DEMOGRAPHIC, CLINICAL AND IMAGING CHARACTERISTICS OF NEWLY DIAGNOSED OPTIC PATHWAY GLIOMAS ASSOCIATED WITH NF1: RESULTS FROM THE INTERNATIONAL MULTICENTER NF1-OPG NATURAL HISTORY STUDY. Neuro-Oncology. 2024; 26:0.

Ghosh, A; Li, H; Towbin, AJ; Turpin, BK; Trout, AT. Histogram Analysis of Apparent Diffusion Coefficient Maps Provides Genotypic and Pretreatment Phenotypic Information in Pediatric and Young Adult Rhabdomyosarcoma. Academic Radiology. 2024; 31:2550-2561.

Glaser, K; Schepers, EJ; Zwolshen, HM; Lake, CM; Timchenko, NA; Karns, RA; Cairo, S; Geller, JI; Tiao, GM; Bondoc, AJ. EZH2 is a key component of hepatoblastoma tumor cell growth. Pediatric Blood and Cancer. 2024; 71:e30774.

Green, A; Rubinstein, JD; Grimley, M; Pfeiffer, T. Virus-Specific T Cells for the Treatment of Systemic Infections Following Allogeneic Hematopoietic Cell and Solid Organ Transplantation. Journal of the Pediatric Infectious Diseases Society. 2024; 13:S49-S57.

Gulati, R; Fleifil, Y; Jennings, K; Bondoc, A; Tiao, G; Geller, J; Timchenko, L; Timchenko, N. Inhibition of Histone Deacetylase Activity Increases Cisplatin Efficacy to Eliminate Metastatic Cells in Pediatric Liver Cancers. Cancers. 2024; 16:2300.

Gulati, R; Lutz, M; Hanlon, M; Cast, A; Karns, R; Geller, J; Bondoc, A; Tiao, G; Timchenko, L; Timchenko, NA. Cellular origin and molecular mechanisms of lung metastases in patients with aggressive hepatoblastoma. Hepatology Communications. 2024; 8:e0369.

Hoyt, SB; Finocchio, CJ; Croll, E; Tawa, GJ; Li, H; Ma, L; Li, K; Liu, L; Li, R; Zhang, X; Culver-Cochran, AE; Rosenbaum, JS; Starczynowski, DT; Thomas, CJ. Discovery of IRAK1/4/pan-FLT3 Kinase Inhibitors as Treatments for Acute Myeloid Leukemia. ACS Medicinal Chemistry Letters. 2024; 15:1843-1851.

Ismail, M; Um, H; Salloum, R; de Blank, P; Tiwari, P. MDB-42. RADIOMIC TEXTURAL AND MORPHOLOGICAL-BASED FEATURES TO RISK-STRATIFY PEDIATRIC MEDULLOBLASTOMA PATIENTS. Neuro-Oncology. 2024; 26:0.

Ismail, M; Um, H; Salloum, R; de Blank, P; Tiwari, P. MDB-40. DEFORMATION-HETEROGENEITY RADIOMIC MEASURES TO RISK-STRATIFY PEDIATRIC MEDULLOBLASTOMA PATIENTS: A PRELIMINARY ANALYSIS. Neuro-Oncology. 2024; 26:0.

Ismail, M; Um, H; Salloum, R; Hollnagel, F; Ahmed, R; de Blank, P; Tiwari, P. A Radiomic Approach for Evaluating Intra-Subgroup Heterogeneity in SHH and Group 4 Pediatric Medulloblastoma: A Preliminary Multi-Institutional Study. Cancers. 2024; 16:2248.

Khandelwal, P; Pommert, L. Vitamin A to Keep GVHD Away: Single Oral High-Dose Vitamin A Before Bone Marrow Transplant Reduces Graft-Versus-Host Disease in Pediatric and Young Adult Patients. 2024; 21.

Khoury, R; Grimley, MS; Nelson, AS; Leemhuis, T; Cancelas, JA; Cook, E; Wang, YZ; Heyenbruch, D; Bollard, CM; Keller, MD; Hanley, PJ; Lutzko, C; Pham, G; Davies, SM; Rubinstein, JD. Third-party virus-specific T cells for the treatment of double-stranded DNA viral reactivation and posttransplant lymphoproliferative disease after solid organ transplant. American Journal of Transplantation. 2024; 24:1634-1643.

Knapp, J; Ermoian, RP; Indelicato, DJ; Lee, JY; Perentesis, JP; Perkins, SM; Laack, NN; Chang, J; MacEwan, I; Wolden, SL; Wang, D; Aridgides, PD; Yock, TI. Outcomes Following Radiation Therapy (RT) for Embryonal Tumor with Multilayered Rosettes (ETMR): Results from the Pediatric Proton/Photon Consortium Registry (PPCR). International Journal of Radiation: Oncology - Biology - Physics. 2024; 120:e697.

Kotch, C; de Blank, P; Gutmann, DH; Fisher, MJ. Low-grade glioma in children with neurofibromatosis type 1: surveillance, treatment indications, management, and future directions. Child's Nervous System. 2024; 40:3241-3250.

Kotch, C; Solomon, DA; Wallace, K; de Blank, PM; Li, Y; Mbonglou, F; Reddy, AT; Gutmann, DH; Piotrowski, AF; Fisher, MJ. NFS-08. CLINICAL AND MOLECULAR FEATURES OF HIGH-GRADE GLIOMA IN CHILDREN AND ADULTS WITH NEUROFIBROMATOSIS TYPE 1: A PRELIMINARY ANALYSIS. Neuro-Oncology. 2024; 26:0.

Lazow, M; Baxter, P; Kumar, SS; Mohamad, M; Mackay, A; Stanek, J; Rodriguez, D; Palmer, J; Leach, J; Mikael, L; Jones, C; Mardis, E; Fouladi, M; Drissi, R. PATH-13. MOLECULAR AND BIOLOGY CORRELATIVE RESULTS FROM THE PHASE 1B TRIAL OF UNESBULIN (PTC596) WITH RADIOTHERAPY IN CHILDREN NEWLY-DIAGNOSED WITH DIFFUSE INTRINSIC PONTINE GLIOMA (DIPG) AND HIGH-GRADE GLIOMA (HGG): A REPORT FROM THE COLLABORATIVE NETWORK FOR NEURO-ONCOLOGY CLINICAL TRIALS (CONNECT). Neuro-Oncology. 2024; 26:viii180.

LeBlanc, FR; Breese, EH; Burns, KC; Chang, EK; Jones, LQ M; Lee, L; Mizukawa, B; Norris, RE; O'Brien, MM; Phillips, CL; Perentesis, JP; Rubinstein, J; Pommert, L. Clinical outcomes of hypomethylating agents and venetoclax in newly diagnosed unfit and relapsed/refractory paediatric, adolescent and young adult acute myeloid leukaemia patients. British Journal of Haematology. 2024; 205:1055-1066.

LeBlanc, FR; Grier, DD; Myers, KC; Shimamura, A; Pommert, L. A case of co-occurring acute myeloid leukemia and relapsed diffuse large B-cell lymphoma in a young adult with Shwachman-Diamond syndrome. Pediatric Blood and Cancer. 2024; 71:e31137.

Lenen, A; Waanders, AJ; Bazzi, L; Zhang, H; Lai, J; Plant-Fox, AS; Cluster, A; Crawford, J; Cohen, K; Dickens, D; Fangusaro, J; Lulla, R; Goldman, S; Pillay-Smiley, N. LGG-37. A PHASE III STUDY COMPARING TWO CARBOPLATIN CONTAINING REGIMENS FOR CHILDREN AND YOUNG ADULTS WITH PREVIOUSLY UNTREATED LOW-GRADE GLIOMA. Neuro-Oncology. 2024; 26:0.

Liu, X; Xin, DE; Zhong, X; Zhao, C; Li, Z; Zhang, L; Dourson, AJ; Lee, L; Mishra, S; Bayat, AE; Jankowski, MP; Barton, SK; He, X; Lu, QR. Small-molecule-induced epigenetic rejuvenation promotes SREBP condensation and overcomes barriers to CNS myelin regeneration. Cell. 2024; 187:2465-2484.e22.

Loo, BW; Verginadis, II; Sørensen, BS; Mascia, AE; Perentesis, JP; Koong, AC; Schüler, E; Rankin, EB; Maxim, PG; Limoli, CL; Vozenin, MC. Navigating the Critical Translational Questions for Implementing FLASH in the Clinic. Seminars in Radiation Oncology. 2024; 34:351-364.

Lovvorn, HN; Renfro, LA; Benedetti, DJ; Kotagal, M; Phelps, HM; Ehrlich, PF; Lo, AC; Sandberg, JK; Treece, AL; Gow, KW; Fernandez, CV; Dome, JS; Geller, JI; Mullen, EA. Race and Ethnic Group Enrollment and Outcomes for Wilms Tumor: Analysis of the Current Era Children's Oncology Group Study, AREN03B2. Journal of the American College of Surgeons. 2024; 238:733-749.

Lulla, RR; Buxton, A; Krailo, MD; Lazow, MA; Boue, DR; Leach, JL; Lin, T; Geller, JI; Kumar, SS; Nikiforova, MN; Gajjar, A; Drissi, R; Pollack, IF; Fouladi, M. Vorinostat, temozolomide or bevacizumab with irradiation and maintenance BEV/TMZ in pediatric high-grade glioma: A Children's Oncology Group Study. Neuro-Oncology Advances. 2024; 6:vdae035.

Mascia, A; McCauley, S; Speth, J; Nunez, SA; Boivin, G; Vilalta, M; Sharma, RA; Perentesis, JP; Sertorio, M. Impact of Multiple Beams on the FLASH Effect in Soft Tissue and Skin in Mice. International Journal of Radiation: Oncology - Biology - Physics. 2024; 118:253-261.

McCall, D; Abuasab, T; Rodriguez-Sevilla, JJ; Mohamed, SF; Patnaik, A; Devireddy, K; Arani, N; Sheikh, I; Jamshidi, R; Gibson, A; Issa, G; Cuglievan, B; Kantarjian, H; Garcia-Manero, G. Characteristics and outcomes of children, adolescent, and young adult patients with myelodysplastic neoplasms: A single-center retrospective analysis. Leukemia Research: clinical and laboratory studies. 2024; 144:107563.

McGrady, ME; Ketterl, TG; Webster, RT; Schwartz, LE; Brock, MY; Szulczewski, L; Burke, M; Hommel, KA; Pai, AL H; Mara, CA; Steele, AC; Regan, GG; Norris, RE. Feasibility pilot trial of a tailored medication adherence-promotion intervention for adolescents and young adults with cancer: Study design and protocol. Contemporary Clinical Trials. 2024; 139:107483.

McLaurin, WS; Francisco, BJ; Hooker, KJ; Sheshashayee, N; Khan, MT F; Triana, RR; Rao, MB; Pressey, JG; Krishnan, DG. Antiresorptive and anti-angiogenic drug therapy in the pediatric population with reference to medication-related osteonecrosis of the jaw. International Journal of Oral and Maxillofacial Surgery. 2024; 53:496-502.

Mersich, I; Congrove, S; Horchar, M; Caceres, R; Desai, J; Desai, P; Sallans, L; Haines, J; Menon, R; Stevenson, C; Tavassoli, A; D’Alessandro, A; Phoenix, T; Dasgupta, B. DIPG-17. DYSREGULATED PURINE METABOLISM IN A LETHAL CHILDHOOD BRAINSTEM TUMOR REVEALS NEW TREATMENT STRATEGIES WITH OLD DRUGS. Neuro-Oncology. 2024; 26:0.

Mochizuki, AY; Hummel, TR; Cripe, T; Fouladi, M; Stevenson, CB; Pollack, I; Mitchell, D; Poussaint, TY; Onar-Thomas, A; DeWire-Schottmiller, M; Pillay-Smiley, N. IMMU-17. A PHASE I STUDY OF INTRATUMORAL/PERITUMORAL HERPES SIMPLEX VIRUS-1 MUTANT HSV1716 IN PATIENTS WITH REFRACTORY OF RECURRENT HIGH-GRADE GLIOMAS: A PEDIATRIC BRAIN TUMOR CONSORTIUM STUDY. Neuro-Oncology. 2024; 26:0.

Mochizuki, AY; Nagaraj, CB; Depoorter, D; Schieffer, KM; Kim, SY. Germline PTCH1: c.361_362insAlu alteration identified by comprehensive exome and RNA sequencing in a patient with Gorlin syndrome. American Journal of Medical Genetics, Part A. 2024; 194:e63788.

Mueller, S; Fangusaro, J; Thomas, AO; Jacques, TS; Bandopadhayay, P; de Blank, P; Packer, RJ; Fouladi, M; van Meeteren, AS; Jones, D; Robison, NJ; Partanen, M; Fisher, MJ; Witt, O. Consensus framework for conducting phase I/II clinical trials for children, adolescents, and young adults with pediatric low-grade glioma: Guidelines established by the International Pediatric Low-Grade Glioma Coalition Clinical Trial Working Group. Neuro-Oncology. 2024; 26:407-416.

Murphy, AJ; Brzezinski, J; Renfro, LA; Tornwall, B; Malek, MM; Benedetti, DJ; Cost, NG; Smith, EA; Aldrink, J; Romao, RL P; Paulino, AC; Lo, AC; Geller, JI; Ehrlich, PF. Long-term outcomes and patterns of relapse in patients with bilateral Wilms tumor or bilaterally predisposed unilateral Wilms tumor, a report from the COG AREN0534 study. International Journal of Cancer. 2024; 155:1824-1831.

Odia, Y; Koschmann, C; Vitanza, NA; De Blank, P; Aguilera, D; Allen, J; Daghistani, D; Hall, M; Khatib, Z; Kline, C; McGovern, SL; Khatua, S; Zaky, W; Gardner, SL. Safety and pharmacokinetics of ONC201 (dordaviprone) administered two consecutive days per week in pediatric patients with H3 K27M-mutant glioma. Neuro-Oncology. 2024; 26:S155-S164.

O'Hare, P; Cooney, T; De Blank, P; Gutmann, DH; Kieran, M; Milde, T; Fangusaro, J; Fisher, M; Avula, S; Packer, R; Ashley, DM; Ertl-Wagner, BB; Tabori, U; Hargrave, DR. Resistance, rebound, and recurrence regrowth patterns in pediatric low-grade glioma treated by MAPK inhibition: A modified Delphi approach to build international consensus-based definitions-International Pediatric Low-Grade Glioma Coalition. Neuro-Oncology. 2024; 26:1357-1366.

Papini, C; Mirzaei, SS; Xing, M; Olsson, IT; de Blank, PM K; Lange, KR; Salloum, R; Srivastava, D; Leisenring, WM; Howell, RM; Oeffinger, KC; Robison, LL; Armstrong, GT; Krull, KR; Brinkman, TM. Evolving therapies, neurocognitive outcomes, and functional independence in adult survivors of childhood glioma. Journal of the National Cancer Institute. 2024; 116:288-298.

Pommert, L. Enhancing Risk Stratification for Pediatric B-Cell Acute Lymphoblastic Leukemia: No Longer a ‘PI’ in the Sky Idea?. 2024; 21.

Raskin, SI; de Blank, PM K; Billups, CA; Li, Y; Olson, JM; Leary, SE S. MDB-86. ISOTRETINOIN HAS NO EFFECT ON EVENT FREE SURVIVAL ACROSS HIGH-RISK MEDULLOBLASTOMA MOLECULAR SUBGROUPS WHEN ADDED TO MAINTENANCE CHEMOTHERAPY: A SECONDARY ANALYSIS OF THE CHILDREN’S ONCOLOGY GROUP ACNS0332 DATA. Neuro-Oncology. 2024; 26:0.

Reel, SM; Siegel, RM; Pillay Smiley, N. Pediatric Oncology and Obesity: An Introduction for General Pediatricians. Clinical Pediatrics. 2024; 63:589-593.

Romao, RL P; Aldrink, JH; Renfro, LA; Mullen, EA; Murphy, AJ; Brzezinski, J; Malek, MM; Benedetti, DJ; Cost, NG; Smith, E; Paulino, A; Kalapurakal, JA; Geller, JI; Ehrlich, PF. Bilateral Wilms tumor with anaplasia: A report from the Children's Oncology Group Study AREN0534. Pediatric Blood and Cancer. 2024; 71:e30981.

Roy, B; Knapke, S; Pillay-Smiley, N; Zhang, X; Queen, K; Sisson, R. Current practice of cancer predisposition testing in pediatric patients with CNS tumors in the United States. Pediatric Blood and Cancer. 2024; 71:e30725.

Sabulski, A; Pommert, L. Eculizumab: Inhibiting C5 Earns a High Five in Prospective Pediatric, Multicenter, High-risk Transplant-associated Thrombotic Microangiopathy Study. 2024; 21.

Schafer, ES; Rushing, T; Crews, KR; Annesley, C; Colace, SI; Kaiser, N; Pommert, L; Ramsey, LB; Sabnis, HS; Wong, K; Chi, YY; Bhojwani, D; Wayne, AS; Bernhardt, MB. Optimizing early phase clinical trial washout periods: a report from the Therapeutic Advances in Childhood Leukemia and Lymphoma consortium. Journal of the National Cancer Institute. 2024; 116:1721-1729.

Shulman, DS; Klega, KS; Chen, N; Gohn, E; Henry, D; Choy, E; Cash, T; Schultz, KA P; Mascarenhas, L; Bagatell, R; Maese, LD; London, WB; DuBois, SG; Crompton, BD. Prospective evaluation of pre-treatment ctDNA burden in localized osteosarcoma to identify patients with inferior outcomes: A report from the LEOPARD study. Journal of Clinical Oncology. 2024; 42:11510.

Stieglitz, E; Pommert, L. Risk-stratified Treatment for Pediatric Patients With Newly Diagnosed Juvenile Myelomonocytic Leukemia. 2024; 21.

Thorman, AW; Reigle, J; Chutipongtanate, S; Yang, J; Shamsaei, B; Pilarczyk, M; Fazel-Najafabadi, M; Adamczak, R; Kouril, M; Bhatnagar, S; Hildeman, DA; Medvedovic, M; Herr, AB; Meller, J. Accelerating drug discovery and repurposing by combining transcriptional signature connectivity with docking. Science Advances. 2024; 10:eadj3010.

Vicente-Muñoz, S; Davis, JC; Lane, A; Lane, AN; Waltz, SE; Wells, SI. Lipid profiling of RON and DEK-dependent signaling in breast cancer guides discovery of gene networks predictive of poor outcomes. Frontiers in Oncology. 2024; 14:1382986.

Wright, EN; Billups, C; Li, Y; Rush, S; Salloum, R; de Blank, P. MDB-100. RETROSPECTIVE ANALYSIS OF CUMULATIVE DOSING OF CHEMOTHERAPY AGENTS AND THE EFFECT ON SURVIVAL IN PATIENTS WITH AVERAGE RISK MEDULLOBLASTOMA TREATED ON CHILDRENS ONCOLOGY GROUP STUDY ACNS0331. Neuro-Oncology. 2024; 26:0.

Wright-Nadkarni, ML; Moscato, EL; Stanek, JR; Schaefer, MR; Gerhardt, CA; Ashley, DM; Baxter, PA; Chi, SN; Dorris, K; Fisher, MJ; Murala, M; Mikael, L; Fouladi, M; Lazow, MA. QOL-38. PSYCHOSOCIAL OUTCOMES OF CHILDREN WITH DIFFUSE INTRINSIC PONTINE GLIOMA (DIPG) AND HIGH-GRADE GLIOMA (HGG) –PROSPECTIVE, LONGITUDINAL PROMIS ASSESSMENTS OF PATIENTS ENROLLED ON CONNECT PHASE I CLINICAL TRIALS. Neuro-Oncology. 2024; 26:0.

Wu, PV; Fish, M; Hazard, FK; Zhu, C; Vennam, S; Walton, H; Przybyl, J; Morri, M; Neff, N; West, RB; Nusse, R. Abstract B024: Single cell transcriptomics and patient-derived tumoroids reveal that hepatobiliary lineage programs cooperate with Wnt pathway mutations to drive cell proliferation in hepatoblastoma. Cancer Research. 2024; 84:b024.

Wu, PV; Fish, M; Hazard, FK; Zhu, C; Vennam, S; Walton, H; Wagh, D; Coller, J; Przybyl, J; Morri, M; Neff, N; West, RB; Nusse, R. A developmental biliary lineage program cooperates with Wnt activation to promote cell proliferation in hepatoblastoma. Nature Communications. 2024; 15:10007.

Xin, DE; Liao, Y; Rao, R; Ogurek, S; Sengupta, S; Xin, M; Bayat, AE; Seibel, WL; Graham, RT; Koschmann, C; Lu, QR. Chaetocin-mediated SUV39H1 inhibition targets stemness and oncogenic networks of diffuse midline gliomas and synergizes with ONC201. Neuro-Oncology. 2024; 26:735-748.

Zarnegar-Lumley, S; Pommert, L. Room To Grow: Bosutinib Approved for Newly Diagnosed or Relapsed/Intolerant Pediatric Chronic Myeloid Leukemia. 2024; 21.